CONCURRENT CHEMORADIATION THERAPY

Clinical trials for CONCURRENT CHEMORADIATION THERAPY explained in plain language.

Never miss a new study

Get alerted when new CONCURRENT CHEMORADIATION THERAPY trials appear

Sign up with your email to follow new studies for CONCURRENT CHEMORADIATION THERAPY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New drug combo tested in aggressive lung cancer

Disease control Not yet recruiting

This study is testing whether adding a new immunotherapy drug called adebrelimab to standard chemotherapy and radiation can better control limited-stage small-cell lung cancer. It will enroll 30 patients to see if this combination is safe and effective at keeping the cancer from …

Matched conditions: CONCURRENT CHEMORADIATION THERAPY

Phase: PHASE2 • Sponsor: Peking University Cancer Hospital & Institute • Aim: Disease control

Last updated Mar 31, 2026 12:11 UTC

CONCURRENT CHEMORADIATION THERAPY

Get alerted when new CONCURRENT CHEMORADIATION THERAPY trials appear

New drug combo tested in aggressive lung cancer